Caring Brands (CABR) Return on Capital Employed (2025 - 2026)
Caring Brands (CABR) posted quarterly Return on Capital Employed of 375.21% for Q1 2026, down 56.96% quarter-over-quarter from 239.04% in Q4 2025.
Caring Brands (CABR) Return on Capital Employed (2025 - 2026) Analysis & Trends
Caring Brands' Return on Capital Employed history runs 2 years deep, the most recent figure standing at 375.21% for Q1 2026.
- In Q1 2026, Return on Capital Employed changed N/A year-over-year to 375.21%; the TTM figure through Mar 2026 stood at 375.21% (changed N/A YoY), while the FY2025 annual figure was 202.89%, changed N/A from the prior year.
- Return on Capital Employed for Q1 2026 stood at 375.21%, down from 239.04% in the prior quarter.
- The five-year high for Return on Capital Employed was 239.04% in Q4 2025, with the low at 375.21% in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Caring Brands | 12.14 Mn | 10.32 Mn | - | -428.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -428.51% |
| Mar 31, 2026 | -375.21% |
| Dec 31, 2025 | -239.04% |